MENU
Agenda
  • JUL 02, 2020 2:30 PM SGT
    Polygenic Risk Score analysis for Alzheimer's disease risk
    Richard Pither, PhD
    CEO, Cytox Ltd, United Kingdom
  • JUL 02, 2020 2:00 PM SGT
    Applications of CytoMicroarrays
    Anuradha Udumudi, PhD
    Founder, Genetech, India
  • JUL 02, 2020 2:00 PM SGT
    Customized Theragen PMRA chip : design history and application examples
    Kyung-Won Hong, PhD
    Director, Div. of Healthcare innovation, Theragen Bio Co., Ltd., South Korea
  • JUL 02, 2020 1:30 PM SGT
    Molecular Diagnosis of Genetic Diseases using CE in an era of different technologies
    Ashwin Dalal, MD
    Head, Diagnostics Division, Centre for DNA Fingerprinting and Diagnostics, Hyderabad, Telangana, India
  • JUL 02, 2020 1:30 PM SGT
    Predictive Genomics ; Powering the future of population and personalized health
    Shantanu Kaushikkar, MS, MBA
    Director Product Marketing, Genotyping, Thermo Fisher Scientific, USA
  • JUL 02, 2020 12:45 PM SGT
    AgriSeq™ - Fast and Affordable Genotyping by Sequencing Solution for Breeding Programs
    Srinivas Chadaram, PhD
    Sr. Product Manager, Agrigenomics, Thermo Fisher Scientific, USA
  • JUL 02, 2020 12:45 PM SGT
    Cancer genomics research on tumor clonality and liquid biopsy
    Yosuke Hirotsu, PhD
    Chief Researcher, Genome Analysis Center, Yamanashi Central Hospital, Japan
  • JUL 02, 2020 12:45 PM SGT
    Strategies to normalize miRNA expression in serum and plasma
    Emily Zeringer, PhD
    R&D Staff Scientist, Sample Preparation BioSciences, Th...
    Harita Veereshlingam, PhD
    Senior Product Application Scientist, Genetic Sciences...
  • JUL 02, 2020 12:15 PM SGT
    Authenticating human cells: Knowing exactly what is in your test tube
    Steve Jackson, PhD
    Senior Manager, Product Applications, Thermo Fisher Scientific, USA
  • JUL 02, 2020 12:15 PM SGT
    Identification of genetic loci associated with self-compatibility, pre-harvest sprouting and maturity time using AmpliSeq technology in common buckwheat (Fagopyrum esculentum)
    Ryoma Takeshima, PhD
    Researcher, Institute of Crop Science, NARO, Japan
  • JUL 02, 2020 12:15 PM SGT
    Microsatellite instability analysis for studying immunotherapy and Lynch syndrome-related cancers
    Charles Baudo, PhD
    Molecular Biologist, Thermo Fisher Scientific, USA
  • JUL 02, 2020 11:30 AM SGT
    Use of Ampliseq™ panels to study SARS-CoV-2 and the host response to infection
    Soren Alexandersen, PhD
    Professor and Director, Geelong Centre for Emerging and Infectious Diseases, Australia
  • JUL 02, 2020 11:00 AM SGT
    Genetic Analysis Solutions for SARS-CoV-2 Research ; Applications in Vaccine Research and Population Genomics Studies
    Rachel Formosa, PhD
    Senior Director, Global Market Development, Genetic Sciences Division, Thermo Fisher Scientific, USA
  • JUL 01, 2020 2:30 PM SGT
    Reproductive genetic solution on ion torrent NGS
    Ritu Hari, PhD
    Chief Medical Geneticist, CRAFT hospital and Research centre, India
  • JUL 01, 2020 2:00 PM SGT
    Current Status of Preimplantation Genetic Testing for Reciprocal Translocation Carriers in Koreans
    Youngjoo Jeon, PhD
    Chief Strategic Officer (CSO), Theragen GenomeCare, South Korea
  • JUL 01, 2020 2:00 PM SGT
    Operational strategies in molecular profiling of lung cancers
    Sudha Murthy, MD
    Chief of Pathology & Laboratory, Indo American hospital, Hyderabad, India
  • JUL 01, 2020 1:30 PM SGT
    Experience with Expanded Carrier Screening Assay
    Mohamed Saleem, PhD
    Laboratory Director, GenomixLab, Malaysia
  • JUL 01, 2020 1:30 PM SGT
    Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
    Sohyun Hwang, PhD
    Assistant Professor, CHA Bundang Medical Center, CHA University, South Korea
  • JUL 01, 2020 1:30 PM SGT
    Use of genomic information in a dairy buffalo breeding program
    Rommel Herrera, DVM
    Supervising Science Research Specialist, Philippine Carabao Center, University of the Philippines-Los Banos (UPLB), Philippines
  • JUL 01, 2020 12:45 PM SGT
    Multicentric Evaluation of Oncomine Precision Assay on Ion Torrent Genexus System
    Michael Hummel, PhD
    Head of Molecular Pathology, Charité - Universitätsmedizin Berlin, Institute of Pathology, Germany
  • JUL 01, 2020 12:45 PM SGT
    Understanding long-term microbial community development using capillary electrophoresis
    Kamlesh Jangid, PhD
    Associate Chief Editor for Soil Biology and Biochemistry, National Center for Cell Science, Pune, India
  • JUL 01, 2020 12:45 PM SGT
    Utilization of custom array for dairy cattle in Korea
    Seokhyun Lee, PhD
    Researcher, Dairy Cattle Genetic Improvement Center (DCIC), NACF Agribusiness Group, South Korea
  • JUL 01, 2020 12:15 PM SGT
    Ion Torrent NGS-based simple and intuitive solutions for microbiome research
    Keun-Joon Park, PhD
    LPS (Lead Product Specialist), Thermo Fisher Scientific, South Korea
  • JUL 01, 2020 12:15 PM SGT
    Potential Next Generation, high-throughput and scalable Axiom microarray technology for Agrigenomics applications
    Arjun Kandalam, PhD
    Business Development Manager, Agrigenomics, Thermo Fisher Scientific, India
  • JUL 01, 2020 12:15 PM SGT
    Simplify your journey of molecular profiling with single day NGS
    Jon Sherlock, PhD
    Director of Product Management, Oncology , Clinical Sequencing Division, Thermo Fisher Scientific, USA
  • JUL 01, 2020 11:30 AM SGT
    Implications of Viral Sequencing - The Children's Hospital Los Angeles Experience
    Timothy Triche, MD, PhD
    Co-Director, Center for Personalized Medicine Program, Children's Hospital Los Angeles, USA
  • JUL 01, 2020 11:00 AM SGT
    Genetic Analysis Solutions for SARS-CoV-2 Research ; Applications in Discovery and Epidemiological surveillance research
    Anjali Shah, PhD
    Senior Director, Product Management, Thermo Fisher Scientific, USA
  • SARS-CoV-2 Research
  • JUL 01, 2020 11:00 AM SGT
    Genetic Analysis Solutions for SARS-CoV-2 Research ; Applications in Discovery and Epidemiological surveillance research
    Anjali Shah, PhD
    Senior Director, Product Management, Thermo Fisher Scientific, USA
  • JUL 01, 2020 11:30 AM SGT
    Implications of Viral Sequencing - The Children's Hospital Los Angeles Experience
    Timothy Triche, MD, PhD
    Co-Director, Center for Personalized Medicine Program, Children's Hospital Los Angeles, USA
  • JUL 02, 2020 11:00 AM SGT
    Genetic Analysis Solutions for SARS-CoV-2 Research ; Applications in Vaccine Research and Population Genomics Studies
    Rachel Formosa, PhD
    Senior Director, Global Market Development, Genetic Sciences Division, Thermo Fisher Scientific, USA
  • JUL 02, 2020 11:30 AM SGT
    Use of Ampliseq™ panels to study SARS-CoV-2 and the host response to infection
    Soren Alexandersen, PhD
    Professor and Director, Geelong Centre for Emerging and Infectious Diseases, Australia
  • Applied Genomics Track
    • Microbiome Research
    • JUL 01, 2020 12:15 PM SGT
      Ion Torrent NGS-based simple and intuitive solutions for microbiome research
      Keun-Joon Park, PhD
      LPS (Lead Product Specialist), Thermo Fisher Scientific, South Korea
    • JUL 01, 2020 12:45 PM SGT
      Understanding long-term microbial community development using capillary electrophoresis
      Kamlesh Jangid, PhD
      Associate Chief Editor for Soil Biology and Biochemistry, National Center for Cell Science, Pune, India
    • QC in Genomics
    • JUL 02, 2020 12:15 PM SGT
      Authenticating human cells: Knowing exactly what is in your test tube
      Steve Jackson, PhD
      Senior Manager, Product Applications, Thermo Fisher Scientific, USA
    • JUL 02, 2020 12:45 PM SGT
      Strategies to normalize miRNA expression in serum and plasma
      Emily Zeringer, PhD
      R&D Staff Scientist, Sample Preparation BioSciences, Th...
      Harita Veereshlingam, PhD
      Senior Product Application Scientist, Genetic Sciences...
    • Reproductive Health
    • JUL 01, 2020 1:30 PM SGT
      Experience with Expanded Carrier Screening Assay
      Mohamed Saleem, PhD
      Laboratory Director, GenomixLab, Malaysia
    • JUL 01, 2020 2:00 PM SGT
      Current Status of Preimplantation Genetic Testing for Reciprocal Translocation Carriers in Koreans
      Youngjoo Jeon, PhD
      Chief Strategic Officer (CSO), Theragen GenomeCare, South Korea
    • JUL 01, 2020 2:30 PM SGT
      Reproductive genetic solution on ion torrent NGS
      Ritu Hari, PhD
      Chief Medical Geneticist, CRAFT hospital and Research centre, India
    • JUL 02, 2020 1:30 PM SGT
      Molecular Diagnosis of Genetic Diseases using CE in an era of different technologies
      Ashwin Dalal, MD
      Head, Diagnostics Division, Centre for DNA Fingerprinting and Diagnostics, Hyderabad, Telangana, India
    • JUL 02, 2020 2:00 PM SGT
      Applications of CytoMicroarrays
      Anuradha Udumudi, PhD
      Founder, Genetech, India
  • Agrigenomics Track
  • JUL 01, 2020 12:15 PM SGT
    Potential Next Generation, high-throughput and scalable Axiom microarray technology for Agrigenomics applications
    Arjun Kandalam, PhD
    Business Development Manager, Agrigenomics, Thermo Fisher Scientific, India
  • JUL 01, 2020 12:45 PM SGT
    Utilization of custom array for dairy cattle in Korea
    Seokhyun Lee, PhD
    Researcher, Dairy Cattle Genetic Improvement Center (DCIC), NACF Agribusiness Group, South Korea
  • JUL 01, 2020 1:30 PM SGT
    Use of genomic information in a dairy buffalo breeding program
    Rommel Herrera, DVM
    Supervising Science Research Specialist, Philippine Carabao Center, University of the Philippines-Los Banos (UPLB), Philippines
  • JUL 02, 2020 12:15 PM SGT
    Identification of genetic loci associated with self-compatibility, pre-harvest sprouting and maturity time using AmpliSeq technology in common buckwheat (Fagopyrum esculentum)
    Ryoma Takeshima, PhD
    Researcher, Institute of Crop Science, NARO, Japan
  • JUL 02, 2020 12:45 PM SGT
    AgriSeq™ - Fast and Affordable Genotyping by Sequencing Solution for Breeding Programs
    Srinivas Chadaram, PhD
    Sr. Product Manager, Agrigenomics, Thermo Fisher Scientific, USA
  • Translational Genomics Track
    • Clinical Oncology Research
    • JUL 01, 2020 12:15 PM SGT
      Simplify your journey of molecular profiling with single day NGS
      Jon Sherlock, PhD
      Director of Product Management, Oncology , Clinical Sequencing Division, Thermo Fisher Scientific, USA
    • JUL 01, 2020 12:45 PM SGT
      Multicentric Evaluation of Oncomine Precision Assay on Ion Torrent Genexus System
      Michael Hummel, PhD
      Head of Molecular Pathology, Charité - Universitätsmedizin Berlin, Institute of Pathology, Germany
    • JUL 01, 2020 1:30 PM SGT
      Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
      Sohyun Hwang, PhD
      Assistant Professor, CHA Bundang Medical Center, CHA University, South Korea
    • JUL 01, 2020 2:00 PM SGT
      Operational strategies in molecular profiling of lung cancers
      Sudha Murthy, MD
      Chief of Pathology & Laboratory, Indo American hospital, Hyderabad, India
    • JUL 02, 2020 12:15 PM SGT
      Microsatellite instability analysis for studying immunotherapy and Lynch syndrome-related cancers
      Charles Baudo, PhD
      Molecular Biologist, Thermo Fisher Scientific, USA
    • JUL 02, 2020 12:45 PM SGT
      Cancer genomics research on tumor clonality and liquid biopsy
      Yosuke Hirotsu, PhD
      Chief Researcher, Genome Analysis Center, Yamanashi Central Hospital, Japan
    • Precision Medicine
    • JUL 02, 2020 1:30 PM SGT
      Predictive Genomics ; Powering the future of population and personalized health
      Shantanu Kaushikkar, MS, MBA
      Director Product Marketing, Genotyping, Thermo Fisher Scientific, USA
    • JUL 02, 2020 2:00 PM SGT
      Customized Theragen PMRA chip : design history and application examples
      Kyung-Won Hong, PhD
      Director, Div. of Healthcare innovation, Theragen Bio Co., Ltd., South Korea
    • JUL 02, 2020 2:30 PM SGT
      Polygenic Risk Score analysis for Alzheimer's disease risk
      Richard Pither, PhD
      CEO, Cytox Ltd, United Kingdom
July 1st - 2nd, 2020 10AM Singapore time

APJ Virtual Genetic Solutions Tour 2020



 

Welcome to the APJ virtual Genetic Solutions Tour 2020

Stay Connected, Move Forward Together

Thermo Fisher Scientific is excited to bring you the Genetic Solutions Tour 2020, an online event to support researchers in the Asia-Pacific and Japan (APJ) region stay connected to new developments in key areas of genomics, continue building on your genomics knowledge base, share your research with peers and progress your research to the next stage as to navigate your way through the SARS-CoV-2 outbreak.

This virtual event will showcase how Thermo Fisher Scientific platforms for qPCR, CE, Microarrays and NGS are being applied to solve problems in the areas of microbiome research, infectious diseases, reproductive health, QC in genomics, precision medicine, clinical oncology research and agrigenomics.

The virtual event will be conducted on July 1st and 2nd. The venue will be opened at the following local times, for you to explore the virtual environment. The lectures will start 1 hour after the venue open time.

Each day will consist of 4-5 hours of lectures and interactive sessions on different genomic applications.

Event at a Glance

The event features all the activities that you can expect from a live conference and more! These include auditoriums with different content tracks, exhibit halls featuring educational videos, product demos etc. You can also download scientific posters, our latest application notes, white papers and other collateral for a range of CE, NGS, qPCR and Microarray applications. By attending the event you can also avail of product discounts, free samples, and other offers*.

Thermo Fisher Scientific product and application experts will be standing by to answer your questions regarding product use, application bottlenecks and any other questions you might have. In addition, you can also participate in group discussions with your peers and Thermo Fisher Scientific scientists.

The event will consist of presentations broadly categorized into three content tracks 1) Applied Genomics, 2) Translational Genomics, and 3) Agrigenomics. Each track will begin with webinars on SARS-CoV-2 research and viral vaccine development. Each presentation that you attend in any of these tracks allows you to earn points and reward.

Program

All attendees who participate to completion will receive a “Certificate of Event Completion”

Register for the event today!

 

* Restrictions will apply. For details, please contact Michelle Hwang (michelle.hwang@thermofisher.com)


Speakers

Show Resources
You May Also Like
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
JUL 07, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUL 07, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Fluidigm Infectious Disease and Oncology Virtual Summit Fluidigm technologies are integral to supporting current progress in cancer, immunology and infectious disease research. Fluidigm has...
APR 20, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
APR 20, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 9th Annual Genetics Virtual Week held on April 20-22, 2021! Genetics Virtual Week 2021 will offer a multi-day content-rich program combining stellar exper...
SEP 08, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 08, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 1st Annua...
MAY 05, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAY 05, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce our 3rd Forensic Sciences Virtual Event on May 5, 2021. Join us for this free, one-day event on May 5th as we discuss DNA, chemistry, toxicology, digital fore...
MAR 24, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAR 24, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 4th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 24, 2021. The Cannabis Sciences planning committee will be plannin...
Speakers

  • Soren Alexandersen, PhD
    Professor and Director, Geelong Centre for Emerging and Infectious Diseases, Australia
    Biography
      Soren Alexandersen is a Veterinary Pathologist, Virologist and Epidemiologist specialising in molecular pathogenesis, epidemiology, detection and control of virus infections since 1982. He has worked in Denmark, USA, England and Canada and since October 2015 in Australia as a Professor and Director of the Geelong Centre for Emerging Infectious Diseases (GCEID), a One Health collaborative Centre including Deakin University, Barwon Health/University Hospital Geelong and the CSIRO Australian Animal Health Laboratory.
    • Charles Baudo, PhD
      Molecular Biologist, Thermo Fisher Scientific, USA
      Biography
        Charles Baudo, Ph.D. is a molecular biologist in the Genetic Sciences Division Clinical Vertical at Thermo Fisher Scientific, and his development efforts are focused on oncology applications. Recently, he was the lead developer on the Applied Biosystems™ TrueMark™ MSI Assay, a new MSI detection kit with an expanded marker set and automated analysis. Dr. Baudo previously worked at Genentech where he performed translational research to profile diagnostic biomarkers in gastric cancer. He earned his Doctorate in Cellular and Molecular Biology from Saint Louis University studying nuclear-mitochondrial interactions.
      • Shantanu Kaushikkar, MS, MBA
        Director Product Marketing, Genotyping, Thermo Fisher Scientific, USA
        Biography
          Shantanu Kaushikkar is currently Director Product Marketing, Genotyping at Thermo Fisher Scientific. He part of the Microarray Leadership Team that is responsible for managing the microarray platform. Shantanu started his career in in medical imaging and held various positions at University of Washington in St. Louis, Missouri and Imatron Inc, California. Shantanu has been with Thermo Fisher Scientific for over 18 years in different positions in research and development and in product marketing. During this time he has led teams responsible for managing a diverse product portfolio including genotyping and gene expression microarrays, instruments, software and automation platforms for applications in human disease research and applied markets. He holds a master's degree in Biomedical Engineering from Case Western Reserve University, Cleveland Ohio, an M.B.A. from Santa Clara University, Santa Clara, California and a Bachelor of Science degree in Biomedical Engineering from Bombay University in India.
        • Srinivas Chadaram, PhD
          Sr. Product Manager, Agrigenomics, Thermo Fisher Scientific, USA
          Biography
            Dr. Srinivas Chadaram joined Thermo Fisher Scientific, in 2018, as a Sr. Product Manager, Agrigenomics, in the AgriBusiness Vertical. In this role, he is responsible for the portfolio of products supporting Agrigenomics vertical - including AgriSeq GBS and CE and working with the qPCR and microarrays teams supporting Agrigenomics solutions. Srinivas is based in the Austin, TX. Srinivas brings extensive experience to Thermo Fisher Scientific, with a strong healthcare and life Sciences background. He has been involved in several startups primarily helping in new product & solution development, starting from requirements gathering to commercialization of products. As a product manager at Advanced Liquid Logic, he successfully commercialized and launched Digital Micro fluidics based platform for screening and diagnosis of Rare Diseases and sample-prep platform for next generation sequencing, subsequently acquired by Illumina, Inc.. He also co-founded Aura Life, a natural product healthcare startup; and was in Business Development at MAXIMUS Federal. Srinivas is a graduate of Duke University, Fuqua School of Business with a MBA Degree, PhD in Zoology and Neurobiology from the University of Idaho and DVM from Acharya NG Ranga Agricultural University, College of Veterinary Science, Hyderabad, India. He has published several peer reviewed scientific papers.
          • Ashwin Dalal, MD
            Head, Diagnostics Division, Centre for DNA Fingerprinting and Diagnostics, Hyderabad, Telangana, India
            Biography
              Dr. Ashwin Dalal is a recipient of Gold Medal in his MBBS exams. He did his post-graduation (MD) in Pediatrics from Goa Medical College, Goa University, followed by Super specialization (DM) in Medical Genetics from Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow. He is currently working with Centre for DNA Fingerprinting and Diagnostics, Hyderabad as Staff Scientist and Head of Diagnostics division. The genetic Diagnostic laboratory led by him at CDFD offers comprehensive diagnosis, genetic counselling and prenatal diagnosis of genetic diseases. He was instrumental in establishment of department of Medical Genetics at Nizam's Institute of Medical Sciences (NIMS), Punjagutta, Hyderabad. He is also Adjunct Visiting Professor in the Department of Medical Genetics Kasturba Medical College, Manipal, India. He is founding member and past secretary of Society for Indian Academy of Medical Genetics. He has published more than 100 papers in National and International journals. His research interests include identification of novel genes for single gene disorders and molecular analysis of genetic diseases. He has contributed chapters in textbooks for MBBS and MD (Pediatrics) students. He is also interested in teaching Medical Genetics and has conducted lectures in medical colleges and national conferences. He has been a member of various Task Forces of Department of Biotechnology, Indian Council of Medical Research and Department of Science and Technology, Government of India.
            • Rachel Formosa, PhD
              Senior Director, Global Market Development, Genetic Sciences Division, Thermo Fisher Scientific, USA
              Biography
                Rachel Formosa is the senior director of global market development for the Genetic Sciences Division of Thermo Fisher Scientific.  Her focus is on solutions that span real-time PCR, microarray and sequencing technologies.  Rachel has developed expertise in these technologies over her 20+ years of experience with genetic analysis technologies, including the past ten years with Applied Biosystems products at Thermo Fisher Scientific.
              • Ritu Hari, PhD
                Chief Medical Geneticist, CRAFT hospital and Research centre, India
                Biography
                  Completed MSc human genetics, PhD reproduction genetics from United Kingdom. Board of Genetic Counselling India (BGCI) certified Genetic counsellor. Have previously worked in UK in the field of reproductive genetics. Came back to India and took the biggest challenge to start a full-fledged Medical genetics laboratory in India. Joined CRAFT Hospital in 2013 as Chief Medical Geneticist and established heads the PGD laboratory and takes in charge of all the high-end genetic testing based on NGS. A hospital first In Asia pacific to have the ion torrent S5 XL. Has the credibility of performing first time in INDIA PGD on a tay sach carrier couple and thereby reporting INDIA'S first live birth on a rare mutation for tay sachs. India's first and world's second achondroplasia free baby born after PGD. Successful first-time attempt in India for a delivery of SMN free baby using NGS technology. Have also reported many successful cases of PGD/PGS for chromosomal translocations. Invited as a faculty in many national conferences. Recently felicitated as champion of ISAR year 2020. Has published many chapters and articles in reputed journals and books. Was a part of PGD consensus to frame guidelines for the country as an initiative from ISAR.
                • Rommel Herrera, DVM
                  Supervising Science Research Specialist, Philippine Carabao Center, University of the Philippines-Los Banos (UPLB), Philippines
                  Biography
                    Veterinarian by profession Present position: Supervising Science Research Specialist at the Philippine Carabao Center at the University of the Philippines-Los Banos (UPLB), Laguna, Philippines Presently taking his PhD at the University of New England, NSW, Australia. Topic is on the use of genomic data on a dairy buffalo breeding program.
                  • Yosuke Hirotsu, PhD
                    Chief Researcher, Genome Analysis Center, Yamanashi Central Hospital, Japan
                    Biography
                      Dr. Hirotsu received Master's Degree of Medical Science in 2010 and completed Ph.D. of Medical Science in 2013 at The Tohoku University School of Medicine, Medical Biochemistry, Japan, where he studied the mechanism of transcriptional regulation for environmental stress, Keap1-Nrf2-sMaf system using molecular biology and mouse genetics. After graduation, he then continued to research the cancer genomics and clinical oncology at the Genome Analysis Center, Yamanashi Central Hospital, Japan. His research is focused on the genetic profiles, liquid biopsy and translational research using clinical specimens.
                    • Kyung-Won Hong, PhD
                      Director, Div. of Healthcare innovation, Theragen Bio Co., Ltd., South Korea
                      Biography
                        Education 1) Bachelor's degree, Department of Biology, Pusan national univ. of Korea (1995-2002) 2) M.S, Department of Biology, Pusan national univ. of Korea (2002-2004) Graduation thesis : 'Molecular Feature and Evolution of Y chromosomal DNA in Primates' 3) Ph. D. Department of Applied biology, Gifu univ. of Japan (2004-2007) Graduation thesis : 'Effect of genetic polymorphisms on animal behavior' Brief History 1) 2015. 3. ~ present : Director (chief researcher), Div. of Healthcare innovation, Theragen 2) 2017. 9. ~ present : Adjunct Professor, Institute of digital anit-aging healthcare, Inje Univ. 3) 2013. 8 ~ 2015. 2 : Senior researcher, Department of Bioscience information, KCDC 4) 2011. 4 ~ 2013. 7 : Senior researcher, Department of Genome epidemiology, KCDC 5) 2010. 2 ~ 2011. 3 : Research professor, College of Medicine, Kyung Hee univ. 6) 2008. 7 ~ 2010. 1 : Chief researcher, Laboratory of Biomedical engineering, Kyung Hee univ. 7) 2007. 10 ~ 2008. 6 : Postdoctoral researcher, Department of Animal genomics, National institute of Animal Science Research Interest 1. Genome-Wide Association Study 2. Metagenome Study 3. Telomere Study 4. Methylation Study Research & Development projects 1) Develop personal genome testing service : Disease vulnerability analysis (Hellogene), Wellness beauty care (Genestyle) 2) Develop Bigdata analysis & Mobile app service (Genebanking) 3) Establish Bigdata analysis platform in Theragen Bio (Develop Theragen Precision Medicine Research Array) 4) Co-research : Amorepacific (Skin genome analysis), Dankook Univ. Hospital (Hair loss gene analysis), Ajou Univ. Hospital (Precocious puberty gene analysis) 5) Research Projects : Project of KCDC (Alcohol gene analysis), Project of National research foundation of Korea (Missing child identification gene analysis), Project of Ministry of trade, industry and energy (Jeju optimized cosmetic research), Project of Ministry of trade, industry and energy (Research of Bigdata healthcare based on wearable devise
                      • Michael Hummel, PhD
                        Head of Molecular Pathology, Charité - Universitätsmedizin Berlin, Institute of Pathology, Germany
                        Biography
                          Prof. Dr Michael Hummel is head of the molecular diagnostics at the Institute of Pathology (Charité, Berlin) and a longstanding researcher with a scientific topic for molecular mechanisms in malignant lymphoma (more than 350 high ranking publications). Molecular diagnostics at Charité covers a broad spectrum of assays ranging from simple PCRs for the detection of viral and bacterial infections, complex PCRs for B- and T-cell clonality, RT-PCR based gene expression for breast cancer, FISH for chromosomal alterations and targeted NGS (started in June 2014) for mutation analysis in cancer tissues and liquid biopsies. The samples of many thousands of patients are being analyzed in our molecular lab every year. For the NGS assays, we are running the S5XL/ION Chef workflow as well as Illumina and QIAGEN platforms. Since March 2018, Charité is member of the Thermo Fisher Center of Excellence Program (COEP). In addition to the above described activities Michael Hummel is the director of the central biobank at the Charité and the Berlin Institute of Health (BIH). Furthermore he is Director of the German Biobank Node and Coordinator of the German Biobank Alliance. In this function he is responsible for the coordination and harmonization of the national biobanking activities and for the representation of the German biobank community at the European level in the frame of the biobanking infrastructure BBMRI-ERIC.
                        • Sohyun Hwang, PhD
                          Assistant Professor, CHA Bundang Medical Center, CHA University, South Korea
                          Biography
                            Education Sept 2004 ~ Feb 2010: KAIST, Daejeon, Korea - Major: Bio and Brain Engineering - Ph. D. degree, Feb 2010, System level identification of interactions between cell signaling pathways. Mar 2000 ~ Feb 2002: KAIST, Daejeon, Korea - Major: Biological Sciences - M. S. degree, Feb 2002, Regulation of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells. Mar 1996 ~ Feb 2000: KAIST, Daejeon, Korea - Major: Biological Sciences - B. S. degree, Feb 2000, an honor graduate. Mar 1994 ~ Feb 1996 Hansung Science High School, Seoul, Korea - Certificate of Graduation, Feb 1996 - Experience Sep 2016 ~ Present - Assistant Professor, CHA Bundang Medical Center, CHA University Sep 2015 ~ Aug 2016 - Research Professor, Ewha Research Center for Systems Biology, Ewha Womans University Sep 2012 ~ Aug 2015 - Research Professor, Marcotte Lab., University of Texas at Austin & Network Biology Lab., Yonsei University Mar 2010 ~ Aug 2012 - Postdoctoral fellow, Network Biology Lab., Yonsei University Jun 2010 ~ Jun 2012 - Organizer, a review committee member, Asian Young Researchers conference on Computational and Omics Biology (AYRCOB) Sep 2003 ~ Nov 2007 - Researcher, Korean BioInformation Center, Korea Research Inst of BioSci and BioTech
                          • Steve Jackson, PhD
                            Senior Manager, Product Applications, Thermo Fisher Scientific, USA
                            Biography
                              Dr. Jackson has over 10 years of experience in genetic analysis technologies. As a senior member of the Content Engine R&D team at Thermo Fisher Scientific, he helps develop solutions for the research and healthcare markets, leveraging varied technologies such as capillary electrophoresis, digital PCR, next-generation sequencing, and microarray analysis. Before Thermo Fisher Scientific, he was at Nanostring Technologies running the Field Applications Specialist (FAS) team. He was also an Acting Assistant Professor at University of Washington, Department of Genome Sciences, investigating developmental genetics of Drosophila melanogaster.
                            • Kamlesh Jangid, PhD
                              Associate Chief Editor for Soil Biology and Biochemistry, National Center for Cell Science, Pune, India
                              Biography
                                Dr. Kamlesh Jangid completed his education in Microbiology from SP Pune University and did his Post-doctoral work at The University of Georgia, USA. His group at NCMR studies Microbial Ecology and Systematics, Bioinformatics and Soil Science. He is the Associate Chief Editor for Soil Biology and Biochemistry, Academic Editor for PLOS ONE and Frontiers in Microbiology. He is the President-elect of the Bergey's International Society for Microbial Systematics and an Academic Advisor to the China Agricultural University, Beijing. He has authored some of the most cited articles in Soil Science and has over 50 publications and successful research grants from US-NSF. Dr. Jangid represented India at the Global Soil Biodiversity Conference in China. During his postdoctoral work, he attended the prestigious Kadner Institute organized by the American Society of Microbiologists. Dr. Jangid is a very proactive and approachable researcher deeply committed to community science outreach. His team has developed SP Pune University's first Microbial Ecology Course as a Ph.D. pre-requisite. He actively teaches at various schools, colleges, universities. Through these activities, Dr. Kamlesh Jangid is motivating today's technologically advanced young generation toward scientific research.
                              • Youngjoo Jeon, PhD
                                Chief Strategic Officer (CSO), Theragen GenomeCare, South Korea
                                Biography
                                  Affiliation 2019 Jun ~ Present Division of Product Development, Theragen Genomecare, Korea (CSO, Chief Strategic Officer) 2015 May ~ 2019 May R&D Management Team, GC Genome (Green Cross Genome), Korea (Team Leader) 2014 Feb ~ 2015 Feb Clinical Research Team, TheragenEtex Bio Institute, Korea (Team Leader) 2010 Feb ~ 2014 Jan Institute for Clinical Research, CHA Bundang Medical Center, Korea (Research Associate) Education 2004 Mar ~ 2008 Feb Department of Life Science, University of Seoul, BS 2008 Mar ~ 2010 Feb Department of Life Science, University of Seoul, MS 2010 Mar ~ 2014 Feb Department of Biomedical Science, CHA University, PhD Awards 2013 Dec ~ SongAm Scientific Award, Korean Society of Hemostasis and Thrombosis 2016 Nov ~ Young Scientist Award, The Genetics Society of Korea
                                • Arjun Kandalam, PhD
                                  Business Development Manager, Agrigenomics, Thermo Fisher Scientific, India
                                  Biography
                                    Dr. Arjun Kandalam is currently a Business Development Manager for Agrigenomics responsible for the Asia Pacific Japan region in Thermo Fisher Scientific. Arjun is a PhD in Molecular Oncology and comes with several years of expertise on Axiom microarrays. He also possesses experience in applying NGS technologies to solve problems in both human and agriculture biotechnology. Arjun has worked for Illumina and Affymetrix in the past and has been part of Thermo Fisher Scientific since it acquired Affymetrix in 2016. To Arjun's credit, he has 26 International peer- reviewed research publications in molecular oncology and was a gold medal winning PhD scholar. He was recognized as a best employee, twice by Illumina, for his expertise in offering superior technical support to researchers and for his business development performance in 2012 and 2013 He has also been recognized as Best Business Development employee for genotyping by Affymetrix in 2015.
                                  • Seokhyun Lee, PhD
                                    Researcher, Dairy Cattle Genetic Improvement Center (DCIC), NACF Agribusiness Group, South Korea
                                    Biography
                                      Education (Degree, Major, Name of Organization or University in sequence of the latest year) 2019 - PhD, Department of Dairy Science, Chungnam National University, Korea 2016 - MSci, Department of Dairy Science, Chungnam National University, Korea Work Experience 2019 ~ Now - Researcher, Dairy Cattle Genetic Improvement Center, NACF Agribusiness Group 2016 ~ 2019 - Researcher, Animal Breeding & Genetics Division, National Institute of Animal Science, RDA 2012 ~ 2016 - Researcher, Department of Dairy Science, Chungnam National University, Korea Summary: SeokHyun Lee holds a PhD in statistical genetics. SeokHyun worked at National Institute of Animal Science, and conducted dairy cattle improvement work and research. Seokhyun joined Nonghyup in 2019 to improve dairy cattle. Interests: Animal Breeding, Genetics of Complex Traits, Genomic Selection, Population Genetics, Statistical genetics, Dairy Cattle.
                                    • Sudha Murthy, MD
                                      Chief of Pathology & Laboratory, Indo American hospital, Hyderabad, India
                                      Biography
                                        Dr Sudha S Murthy has over 20 years of experience as Chief of Pathology & Laboratory. Medicine at Basavatarakam Indo American Cancer Hospital & Research Institute, a premier tertiary care cancer hospital and advisor to many diagnostic labs trying to set up molecular assays and other cancer diagnostic testing. She brings to the table high end cancer diagnostic skills and liasoning skills with Oncologists. Her experience in healthcare management has helped her scale up diagnostic business with quality and lean processes addressed in this niche area of cancer. She is recognised for her efforts in raising the bar of oncopathology practice by envisioning and designing an integrated lab that comprises of basic histopathology, hematopathology to high end molecular lab with technologies like Next Generation Sequencing (NGS), RT PCR, FISH, 13 color flow cytometry etc. A passionate teacher, who has been awarded Teacher of Eminence in Pathology by the Association of NBE accredited institutes of Telangana and Andhra Pradesh in 2019, is known for grooming pathologists to excel in encouraging creative work environments. She has over 80 publications in peer reviewed national and international journals and several awards and honours to her credit. She is keen on leveraging the potential of NGS by bringing down the cost and making it accessible to cancer patients irrespective of their socioeconomic status and hopes to work with NGOs and policy makers to make this a reality.
                                      • Keun-Joon Park, PhD
                                        LPS (Lead Product Specialist), Thermo Fisher Scientific, South Korea
                                        Biography
                                          Education ~ 2003.09, Kyoto University / PhD / Bioinformatics Employment History ~ Present, Thermo Fisher Scientific / Seoul, Korea / LPS (Lead Product Specialist). ~ 2010.09, National Institute of Health, Korea CDC / Seoul, Korea / Principal Researcher. ~ 2006.03, Human Genome Center, The University of Tokyo / Tokyo, Japan / Researcher. ~ 2005.03, Computational Biology Research Center / Tokyo, Japan / AIST Research Staff.
                                        • Richard Pither, PhD
                                          CEO, Cytox Ltd, United Kingdom
                                          Biography
                                            Richard Pither has been involved in the development of diagnostic and therapeutic pharmaceutical products for more than 25 years. He has been CEO at Cytox for the past 7 years, a precision medicine working on developing and commercialising a new diagnostic technology for assessing Alzheimer's Disease risk. Prior to Cytox, Richard has held senior R&D and leadership positions in global pharmaceutical companies including GE Healthcare/Amersham plc, Lorantis and UCB-Celltech. During this time, he was involved in the development of a novel 18F-PET radiopharmaceutical for imaging amyloid deposition in the brains of Alzheimer's disease patients.
                                          • Mohamed Saleem, PhD
                                            Laboratory Director, GenomixLab, Malaysia
                                            Biography
                                              Dr. Saleem received his PhD in Medical Genetics from the University Putra Malaysia in 2011. From 2013-2016, Dr. Saleem did a postdoctoral fellowship at the University Sains Malaysia working on Acute Myeloid Leukaemia and Pharmacogenomics. Since 2016 he joined Advanced Genomics (GenomixLAB®) in Malaysia as the Laboratory Director. GenomixLAB® is a private molecular diagnostic service provider working especially in the domains of reproductive genetics and cancer genetics mostly using ION Chef and S5 workflows. Dr. Saleem has been working in in the filed of Genetics diagnostics since 2011.
                                            • Anjali Shah, PhD
                                              Senior Director, Product Management, Thermo Fisher Scientific, USA
                                              Biography
                                                - 14 years at the company in Product Marketing functions - B.S Honors Biology and B.A. Spanish from University of Illinois, Urbana-Champaign - Ph.D. Genetics and Development, Columbia University, New York, NY - Postdoctoral fellow, Howard Hughes Medical Institute, University of California, San Francisco
                                              • Jon Sherlock, PhD
                                                Director of Product Management, Oncology , Clinical Sequencing Division, Thermo Fisher Scientific, USA
                                                Biography
                                                  I completed my B.Sc. in Genetics at University College London (UCL) in 1993, before moving on to start a research career at Guys Hospital Medical School. I moved back to UCL where I completed my PhD. in pre-implantation and pre-natal research & diagnostics. I then held a post-doctoral research and lecturing post in the Obstetrics & Gynaecology Department at University College Hospital where I managed a team developing new diagnostic tests. After two sabbaticals setting up molecular diagnostic testing laboratories in Europe, I left academia to join my present company. After roles in Technical Support, Sales, Marketing and Business Development I now reside in California and run the oncology Product Management group in the Clinical Sequencing Division developing and managing diagnostic & research products including the first IVD labelled NGS kit for solid tumour testing as well as assays for immune oncology, cell-free, hemato-Oncology and paediatric cancer testing. As well as product development I also represent the organisation on scientific boards and collaborations.
                                                • Ryoma Takeshima, PhD
                                                  Researcher, Institute of Crop Science, NARO, Japan
                                                  Biography
                                                    I obtained my Ph.D. from the Hokkaido University in Japan and joined the Institute of Crop Science, NARO of Japan in 2017. My interests are in the research area focused on the genetic mechanism of agronomical trait and a unique mating system of common buckwheat (Fagopyrum esculentum). I also attempt to breed new cultivars to improve the quality/quantity of products in buckwheat.
                                                  • Timothy Triche, MD, PhD
                                                    Co-Director, Center for Personalized Medicine Program, Children's Hospital Los Angeles, USA
                                                    Biography
                                                      Dr. Timothy Triche is the Co-Director for the Children's Hospital Los Angeles (CHLA) Center for Personalized Medicine. He previously served as Chief of the CHLA Department of Pathology and Laboratory Medicine for over 20 years. Prior to joining CHLA, Dr. Triche was Head of Molecular Diagnostics in the Laboratory of Pathology at the National Cancer Institute. At CHLA, he directs a cancer genomics, biology, and nanotechnology laboratory research program. He has developed numerous biomarker profiles for cancer diagnosis, prognosis and treatment as part of the NCI's Director's Challenge, SPECS and TARGET initiatives. His focus is on functional characterization of non-coding RNAs in cancer and development.
                                                    • Anuradha Udumudi, PhD
                                                      Founder, Genetech, India
                                                      Biography
                                                        - PhD in Human Genetics - 25 years experience in medical genetics - Post-doctoral work in USA at UMDNJ Medical school (New Jersey), Walksman Institute (New Jersey), Integrated Lab Systems (North Carolina) - Worked at Laboratory Corporation of America's Medical Genetics division - Young Scientist Award (Environmental Mutagen Society, USA), other international awards - Published papers in several reputed international journals, and authored several book chapters - Over 350 CME lectures delivered at national and state level conferences (& 200 awareness camps) - Designed and developed many novel genetics diagnostic tests and panels, standardized more than 300 molecular diagnostic tests - Designed world's first and most comprehensive reproductive genomics panels, presented at ACMG 2019 - Seattle (USA)
                                                      • Harita Veereshlingam, PhD
                                                        Senior Product Application Scientist, Genetic Sciences Division, Thermo Fisher Scientific, USA
                                                        Biography
                                                          Harita Veereshlingam is a Senior Product Application Scientist in the Genetic Sciences Division at Thermo Fisher Scientific. She has over 10 years of experience in product development with an emphasis on real time PCR assays for gene expression and miRNA analysis. In her current role, Harita is responsible for product portfolio growth through the development of novel applications, customer collaborations, technical notes, and webinars. She lives by and is a strong proponent of sustainable living. She has a PhD in Molecular Biology from the University of North Texas.
                                                        • Emily Zeringer, PhD
                                                          R&D Staff Scientist, Sample Preparation BioSciences, ThermoFisher Scientific, USA
                                                          Biography
                                                            Emily has worked as part of R&D at the Austin site for over 15 years. During her tenure, she has lead and contributed to multiple projects including sample preparation and analysis of nucleic acids (including real-time PCR) from a wide range of sample types, library preparation for sequencing, and purification and analysis of exosomes. Recently and for the past several years, her efforts have shifted to the development of high-throughput and automated DNA/RNA extraction methods from clinical samples (such as biofluids) for use within larger analysis workflows ranging from such as Pharmacogenomics, Pathogen/Microbial Detection, Disease studies and Biomarker studies.
                                                          Help

                                                          General LabRoots Questions

                                                          email support@labroots.com  

                                                          Virtual Events and Webinars

                                                          Supported Configurations

                                                          • Operating System Internet Explorer Firefox Chrome Safari
                                                            Vista IE8+ FF10+ Chrome15+
                                                            Windows 7 IE8+ FF10+ Chrome15+
                                                            Windows 8 IE10 FF10+ Chrome15+
                                                            Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                          • Cookie settings: session cookies enabled
                                                          • Browser configuration must have JavaScript enabled
                                                          • Adobe Flash player 10.2 or later

                                                          To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                          Internet Connection

                                                          • A minimum of 100Kbps is recommended for audio-only events
                                                          • A minimum of 300Kbps is recommended for speaker on-video events

                                                          Computer Equipment

                                                          • Screen Resolution: Minimum 1024x768
                                                          • Video Card: 65,000 colors minimum
                                                          • Sound card and speakers (or headphones) for hearing webcast in full format
                                                          • Audio Card: 16-bit minimum
                                                          • RAM: 512MB of free RAM

                                                          Firewall Protocol

                                                          • HTTP on port 80 or HTTPS on port 443
                                                          • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                          • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                          Work-At-Home Attendees

                                                          • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                          For A Seamless Experience

                                                          When using a mobile device, FREE Mobile Apps are available:

                                                          - For viewing Webinars:

                                                          - For viewing Virtual Events

                                                          Attendee Guide

                                                          • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                          Virtual Event and Webinar Support:

                                                          Continuing Education (CME/CE) Support

                                                          Loading Comments...
                                                          Show Resources
                                                          Attendees
                                                          • See more